Rua and Cann reach positive resolution in legal proceedings

Rua Bioscience advises that it has reached a settlement with Cann Group Limited (ASX:CAN), following legal proceedings initiated by Rua in February 2024.

As part of the legal proceedings, both parties undertook mediation which had led to this settlement. Rua Bioscience and Cann Group have executed new supply agreements to support their respective operations in the New Zealand and Australian medicinal cannabis markets. The commercial terms of the settlement are confidential and take effect immediately.

ENDS

• Rua and Cann reach positive resolution in legal proceedings

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

February 20th Morning Report
SCL - Chief Financial Officer Transition
BLS - Strong YTD performance
CEN announces opening of NZ$75 million Retail Offer
AIA - 1H26 Interim Results
February 19th Morning Report
TWL - Share Purchase Plan Results
GMT revaluation, unit buyback and proposed structure update
Devon Funds Morning Note - 17 February 2026
CEN - Contact successfully completes NZ$450m Placement